Gartner Research

Assessment of Track-and-Trace and Serialization Legislation for Life Science Companies, Africa

Published: 16 February 2015

ID: G00271025

Analyst(s): Andrew Stevens

Summary

Counterfeit products are flooding into African countries, which have yet to implement track-and-trace and serialization legislation. Supply chain leaders responsible for compliance, with revenue streams in the region, must assess products at immediate risk and act urgently to protect patient safety.

Table Of Contents

Analysis

  • Counterfeit Medicines in Africa Present a Serious and Immediate Challenge
  • Assess Near-Term Risk Profiles for Products Sold in Africa — Don't Wait for Legislation
    • Supply Chain Planning
    • Logistics and Distribution
    • Networking, Data and Business Intelligence
  • For the Highest-Risk Products, Assess and Deploy Mobile Supply Chain Technology Authentication Solutions Immediately
    • Mobile Scanning and Bar Code Solutions
    • SMS Text Messaging With Special Tamper-Evident Labels
    • Chemical or Molecular Screening Technology
  • Secure the Supply Chain by Introducing Prequalification and Quality-Testing Steps Close to Points of Dispensation or Patient Use

Gartner Recommended Reading

©2019 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.